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Abstract
The Eph receptor tyrosine kinases interact with their ephrin ligands on adjacent cells to facil-
itate contact-dependent cell communication. Ephrin B ligands are expressed on T cells and
have been suggested to act as co-stimulatory molecules during T cell activation. There are
no detailed reports of the expression and modulation of EphB receptors on dendritic cells,
the main antigen presenting cells that interact with T cells. Here we show that mouse splenic
dendritic cells (DC) and bone-marrow derived DCs (BMDC) express EphB2, a member of
the EphB family. EphB2 expression is modulated by ligation of TLR4 and TLR9 and also by
interaction with ephrin B ligands. Co-localization of EphB2 with MHC-II is also consistent
with a potential role in T cell activation. However, BMDCs derived from EphB2 deficient
mice were able to present antigen in the context of MHC-II and produce T cell activating
cytokines to the same extent as intact DCs. Collectively our data suggest that EphB2 may
contribute to DC responses, but that EphB2 is not required for T cell activation. This result
may have arisen because DCs express other members of the EphB receptor family, EphB3,
EphB4 and EphB6, all of which can interact with ephrin B ligands, or because EphB2 may
be playing a role in another aspect of DC biology such as migration.
Introduction
Erythropoietin-producing hepatocellular (Eph) receptors were first discovered in 1987 [1] and
are the largest family of receptor tyrosine kinases. They have been split into two groups based
on sequence conservation—the A and B families—and these receptors bind Ephrin A and B
ligands respectively. There are now several reports describing the expression of Eph receptors
and Ephrin ligands of both the A family [2–7] and the B family [3, 8–14] on the surface of
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immune cells, yet the function of this family of molecules in immune responses is currently
unclear.
T cells have been reported to express both Ephrin ligands and Eph receptors on their sur-
face. Ephrin B ligands have been shown to play a role in the development of T cells in the thy-
mus [9, 13], possibly by stabilizing the expression of the IL-7Rα at the surface of the
developing T cells [15]. T cells require co-stimulatory signals in addition to ligation of the T
cell receptor (TCR) to become activated. Ephrins B1 [12], B2 [10] and B3 [11] have been sug-
gested to function in co-stimulation of T cells. If Ephrin B ligands are co-stimulatory mole-
cules, they should ligate with EphB receptors expressed on the surface of dendritic cells (DC),
the main antigen presenting cells that activate T cells. The ligation of Ephrin ligands with Eph
receptors results in bi-directional signaling [16] that may act to potentiate signals in the T cell
as well as the activating DCs. Indeed, Ephrin B expression on T cells has been shown to be
required for optimal IL-6 receptor ligation-induced STAT3 phosphorylation in T cells [9] dem-
onstrating that ligation with EphB receptors has the potential to induce signaling pathways
that may influence the response of T cells to cytokine stimulation.
Although there have been reports of Eph receptor expression on some human DC subsets
with EphB3 expressed by Langerhans cells, EphA2 and EphA7 expressed by interstitial DCs
and EphB1 on plasmacytoid DCs [3, 17, 18] there have been no reports investigating how these
molecules are regulated on DCs or whether they alter T cell responses upon activation, as
might be expected from co-stimulatory molecules. Given that monocytes/macrophages express
EphB2 [19, 20] and Ephrin B ligands are present on T cells, we hypothesized that EphB2 would
be expressed on DCs and its deficiency on this immune cell type might result in altered T cell
expansion and activation. The data reported here show that splenic DCs and bone marrow-
derived DCs (BMDCs) express EphB2 on their surface and that this receptor is up-regulated by
both Toll-like receptor (TLR) ligation and ligation with Ephrin B ligands. We show that EphB2
co-localizes with major histocompatibility complex (MHC)-II on BMDCs but EphB2-/- defi-
ciency on BMDCs does not impair T cell activation. Taken together, these results reveal that
EphB2 is expressed by DCs yet is not required to activate T cells. This may be due to the expres-
sion of other EphB receptors on BMDCs including EphB3, EphB4 and EphB6 that may func-
tionally compensate for the absence of EphB2. However this does not exclude another role for
EphB2 on DCs, such as in facilitating migration to the draining lymph nodes from areas of
antigenic challenge.
Materials and Methods
Ethics statement
Animals were housed in sterile cages and kept under conventional conditions. All experiments
were approved by the Emory University Institute for Animal Care and Use Committee and
conducted in accordance with approved guidelines.
Mice
Female C57BL/6 and T cell receptor OT-II transgenic mice [21] were maintained by the Divi-
sion of Animal Resources on the Emory campus or purchased from The Jackson Laboratory
(Bar Harbor, ME, USA). EphB2-/- mice on a C57BL/6 background [22] were a kind gift from
Jonathan Gibbins (University of Reading, UK) and were re-derived and bred under a heterozy-
gote breeding system to allow comparison of homozygote EphB2-/- mice with wild type litter-
mate control mice. Experiments were conducted at the Emory University Department of
Pediatrics Animal Facility on female mice aged 6–12 weeks that were fed diet 5001 (LabDiet,
MO, USA) and given food and water ad libitium. Mice were euthanized by CO2 inhalation.
EphB2 Expression and Function on Dendritic Cells
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Cell lines
The interleukin (IL)-2 sensitive cell line, HT-2 (American Type Culture Collection (ATCC),
Manassas, VA) was maintained in RPMI-1640 supplemented with 10% heat inactivated fetal
calf serum (FCS) (PAA Laboratories), penicillin (100U/ml) streptomycin (100μg/ml), L-gluta-
mine (2mM), 2-mercaptoethanol (50μM), sodium pyruvate (1mM), 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) (10mM) (all Life Technologies / Invitrogen) plus
human recombinant IL-2 (150U/ml) (PeproTech). The T cell hybridoma MF2.2D9 with T cell
receptors reactive to chicken ovalbumin (OVA)257-278 (a kind gift from Kenneth Rock, Univer-
sity of Masachusetts [23]) was cultured in DMEM supplemented with 10% FCS, penicillin
(100U/ml) streptomycin (100μg/ml), L-glutamine (2mM), 2-mercaptoethanol (50μM), sodium
pyruvate (1mM), HEPES (10mM).
Mouse DC Preparations
For the isolation of BMDCs, mice (n = 2) were sacrificed by CO2 inhalation and bone marrow
was removed from the femur and tibia by flushing the shaft with Iscoves’Modified Eagles
Medium (IMDM) (Life Technologies / Invitrogen). Red blood cells (RBC) were lysed using
RBC lysis buffer (eBioscience), and the remaining cells were plated in a 6-well tissue culture
plate at a density of 106 cells/ml per well in IMDM supplemented with 10% heat inactivated
FCS (PAA laboratories), penicillin (100U/ml) streptomycin (100μg/ml), L-glutamine (2mM),
2-mercaptoethanol (50μM), sodium pyruvate (1mM), HEPES (10mM) (all Life Technologies /
Invitrogen) with additional recombinant mouse granulocyte macrophage colony stimulating
factor (GM-CSF) (Miltenyi Biotech) at a concentration of 40ng/ml. The culture medium was
replenished at days 3 and 5, and the loosely adherent BMDCs were harvested at day 7 of culture
and used for further experiments. To prepare splenic DCs, spleens from 10 mice were incu-
bated in Liberase TL (Roche) for 30 minutes at 37°C at a concentration of 0.4mg/ml and sple-
nocytes aseptically isolated before lysing RBCs with RBC lysis solution (eBioscience).
CD11c+ cells were purified using Miltenyi MACS separation beads (Miltenyi Biotech) accord-
ing to the manufacturer’s instructions.
Human DC preparations
Human blood was used for isolation of human DCs and obtained through a blood donation
center (LifeSouth; http://www.lifesouth.org/drives/). Human monocyte derived dendritic cells
(MoDC) (a kind gift from Jan Mead, Emory University, USA) were prepared according to the
protocol by Bedi and Mead [24]. Briefly, peripheral blood mononuclear cells (PBMCs) were
isolated from buffy coats of heparinized blood from healthy volunteers (LifeSouth, US) and
CD14+ cells isolated and cultured in the presence of recombinant human GM-CSF and IL-4
for 5 days until cells up-regulated CD11c and CD11b.
DC Stimulation
BMDCs (1x 106) were cultured with lipopolysaccharide (LPS) from Salmonella minnesota
(Alexis) at a concentration of 1μg/ml or CpG1668 (TCCATGACGTTCCTGATGCT with
phosphorothioate linkages; Life Technologies / Invitrogen) at a concentration of 1μM for dif-
ferent amounts of time. Samples were plated in duplicate. In some experiments BMDCs were
cultured on plate-bound recombinant mouse Ephrin B1-Fc or Ephrin B2-Fc chimeric proteins
(R and D systems) at a concentration of 5 μg/ml. Stimulation was carried out in the presence or
absence of 20ng/ml of recombinant mouse interferon-γ (IFN-γ) (eBioscience).
EphB2 Expression and Function on Dendritic Cells
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Flow Cytometry
Cells were incubated with Fc block (clone 2.4G2) for 20 minutes on ice before surface staining
with fluorescently labelled CD11c (clone N418), MHC-II (clone M5/114.15.2), CD4 (GK15),
CD8 (clone 53–6.7), Vα2 TCR chain (clone B20.1) antibodies (all from eBioscience). For detec-
tion of EphB receptors and Ephrin molecules on splenic CD11chi DC, cells were incubated
with recombinant mouse EphB2-Fc or mouse Ephrin B2-Fc chimeric proteins (R and D sys-
tems) at a concentration of 200ng/ml for 30 minutes on ice. Bound molecules were detected by
incubation with a secondary biotinylated anti-human IgG Fc antibody (eBioscience) for 20
minutes followed by 15 minutes of incubation with APC-conjugated strepatavidin
(eBioscience). T cell cytokines were detected by intracellular cytokine staining after fixation of
cells in 2% paraformaldehyde solution and permeabilization using 0.5% saponin solution
(Sigma).
Confocal Microscopy Analysis
BMDCs (105 cells) were cytospun onto glass slides and fixed with 2% paraformaldehyde. Slides
were stained with the following primary antibodies or isotype controls: anti-mouse EphB1
polyclonal antibody at a 1:500 dilution (Pierce), anti-mouse EphB2 (clone 512001 or clone
512013 at 2μg/ml; R&D systems), anti-mouse EphB3 monoclonal antibody (clone 521002;
R&D systems), anti-mouse EphB4 monoclonal antibody (clone 117808; R&D systems), anti-
mouse EphB6 monoclonal antibody (clone 5D8; Novus Biological) or MHC-II-FITC (clone
M5/114.15.2; eBioscience), using standard methodology. Slides were then stained with second-
ary rat or rabbit antibodies labelled with NorthernLights 493
1
or NorthernLights 577
1
(R&D
Systems) at a dilution of 1:1000 and nuclei counterstained with mounting medium containing
DAPI (VectorShield). Images were captured using a Carl Zeiss confocal microscope and ana-
lyzed using Image J software.
Quantitative Real-Time PCR (qRT-PCR)
Cells were homogenized in RNA Stat60
1
(Tel-Test Inc., TX, USA) and total RNA extracted
using standard phenol-chloroform protocols followed by DNase treatment of RNA extracted
using Nucleospin RNA-II purification kit (Nachery-Nagel). A total of 100ng of RNA per sam-
ple was converted into cDNA using Superscript II (Life Technologies) at 42°C for 50min, 70°C
15min, in the presence of 5μM oligo (dT)16-18, 5mM Dithiothreitol (DTT), 0.5mM dNTPs (all
Life Technologies), 8U RNAsin (Promega), 50mM Tris-HCl pH8.3, 75mM KCl and 3mM
MgCl2. The cDNA was treated with 2.5U RNAse H (Affymetrix) at 37°C for 20min to remove
any remaining RNA residues. Real-time qPCR reactions were performed using Quantitect
SYBR Green PCR reagent (Qiagen). PCR amplification was performed with 5μl cDNA sample
(diluted 1:10), 2μM of each primer and 7μl of QPCR SYBR green mix. Plates were run using an
Applied BioSystems FAST 7000 Sequence detection system (ABI Prism FAST 7000). Primer
sequences are shown in supporting information S1 Table. Transcripts were normalized to two
different housekeeping genes (Ubiquitin and β-actin) and expression levels calculated using
the 2-ΔΔCt method [25].
Western Blot
BMDCs lysates were prepared with radio-immunoprecipitation (RIPA) buffer containing 1x
EDTA/proteinase-phosphatase inhibitor cocktail (Pierce). The lysate supernatant was stored at
-80°C until used for immunoblotting. Protein extracts were separated by SDS-PAGE electro-
phoresis and blotted onto nitrocellulose membrane. Blots were blocked in 5% fat free milk in
EphB2 Expression and Function on Dendritic Cells
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1x TBS-Tween 20 for 1 hour and then incubated overnight with an HRP-tagged mouse anti-
phospho-Tyrosine-100 antibody at a 1:500 dilution. Anti-mouse β-actin (clone AC-15; dilution
1:1000; Pierce) was used as a loading control. Blots were then stained for 1 hour with rat HRP-
conjugated secondary anti-IgG (R and D Systems) at a dilution of 1:2000. Finally, blots were
developed using ECL substrate as per the manufacturer’s instructions (Pierce) and bands quan-
tified using densitometry measurements on Image J software.
T cell Activation Assay
1 x 105 BMDCs were incubated with 5 x 105 OT-II T cells containing T cell receptors reactive
to OVA323-339 and 1mg/ml of OVA (Sigma). T cells were purified from single cell splenocyte
preparations from 5 naïve OT-II mice using CD4+ Miltenyi MACs beads according to the
manufacturer’s instructions or sorted into CD4+Vα2TCR+ cells on a FACS Aria cell sorter
(Becton Dickinson). After 5 days, cultured cells were incubated on plate bound anti-CD3 (clo-
ne17A2; eBioscience) in the presence of 2μg/ml of anti-CD28 (clone 37.51; eBioscience) and
10μg/ml of brefeldin A (Sigma) for 6 hours before undergoing surface and intracellular staining
for analysis by flow cytometry.
Antigen Presentation Assay
BMDCs were incubated in varying numbers with 2 x 104 MF2.2D9 and either 1 mg/ml of OVA
protein or 1μM endotoxin-free OVA257-278 peptide (SIINFEKLTEWTSSNVMEERKI) (Biosyn-
thesis) for 18 hours in triplicate. The supernatants were tested for IL-2 secretion using an IL-2
sensitive cell line (HT-2 cell) and proliferation was evaluated using an ATP-based lumines-
cence cell proliferation and viability assay following the manufacturer’s instruction (Cell Titer-
Glo
1
Luminescent, Promega). Luminescence was read on a microplate scintillation and lumi-
nescence counter (TopCount NXT, PerkinElmer).
Luminex
Cytokine analysis was performed using Luminex reagents from Life Technologies / Invitrogen
according to the manufacturer’s instructions and a Luminex1 100/200 Analyzer.
Statistical analysis
Each experiment was completed at least three times, each with an independent biological prep-
aration of cells. Statistical analysis was performed using the Kruskal Wallis one-way analysis of
variance and Dunn’s multiple comparison post-test in Graph Pad Prism software. A P value
<0.05 was considered statistically significant.
Results
Mouse DCs express EphB2 receptor
To assess whether mouse DCs express EphB2 receptors, we incubated naïve C57BL/6 mouse
splenocytes with recombinant mouse Fc-Ephrin B2, the main ligand for EphB2 receptor. The
binding of Ephrin B2 ligand onto expressed EphB receptors was detected by flow cytometry
and a subset of CD11chi DCs bound recombinant EphrinB2-Fc chimeric ligand over and above
binding of anti-human IgG alone (used as a negative control) (Fig 1A). This indicates that
mouse splenic DCs express EphB receptors. We did not detect any binding of EphB2-Fc chime-
ric ligand over and above the binding of anti-human IgG alone suggesting that splenic CD11chi
DCs do not express Ephrin B ligands on their surface (Fig 1A). Since there is redundancy in the
binding of Eph receptors to ephrin ligand, we assessed whether DC specifically express EphB2.
EphB2 Expression and Function on Dendritic Cells
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Immunohistochemistry was performed on BMDCs with anti-mouse EphB2 antibody. Labelled
secondary antibody only bound to DCs incubated with anti-EphB2 antibody and not those
incubated with an isotype control antibody demonstrating a baseline expression of this mole-
cule on unstimulated BMDCs (Fig 1B).
EphB2 is upregulated on BMDCs in response to TLR ligation
To address whether baseline EphB2 expression could be modulated on activated DCs, BMDCs
were incubated with bacterial TLR ligands LPS and CpG in the presence or absence of IFN-γ
for different amounts of time. The transcription of EphB2 in response to these stimuli was
monitored by qPCR. Transient upregulation of EphB2mRNA occurred 3 hours after incuba-
tion with LPS or CpG (Fig 2A and 2B) and this was not significantly enhanced by additional
stimulation with recombinant IFN-γ. When BMDCs were stimulated with TLR agonists with
or without IFN-γ, upregulation of EphB2mRNA was between 2.5 and 6 fold increase compared
Fig 1. Splenic CD11chi and bonemarrow-derived DCs express EphB2. (A) Eph receptor expression on the surface of naïve splenic CD11chi DCs was
detected by incubation with Ephrin-B2-Fc chimeric protein and binding was detected using a biotinylated anti-Fc antibody and streptavidin-APC (SA-APC) using
flow cytometry. (B) The expression of EphB2 on BMDCs incubated with anti-EphB2 antibody or isotype control (IgG2a) detected by immunofluorescence.
Magnification 40x; Scale bar, 10μm.
doi:10.1371/journal.pone.0138835.g001
EphB2 Expression and Function on Dendritic Cells
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to unstimulated BMDCs at the same time point. Interestingly the magnitude of the change in
EphB2 transcription was in the same range as that for the known co-stimulatory molecules
CD80 and CD86 (Fig 2A and 2B). The stimulation with LPS and CpG was sufficiently adequate
to upregulate IL-12p40mRNA by ~700 fold (Fig 2A) and ~1500 fold (Fig 2B) respectively dem-
onstrating that the stimulation by LPS and CpG was successful. There was no significant
Fig 2. EphB2 expression on BMDCs can bemodulated by ligation with Toll-like receptor ligands. (A) BMDC were incubated with a Toll Like receptor
(TLR)-4 agonist (lipopolysaccharide (LPS) 1μg/ml) and (B) a TLR-9 agonist (CpG1668 1μM) with or without recombinant mouse interferon (IFN)-γ at a
concentration of 20ng/ml. EphB2mRNAwas quantified by qPCR at different time points post-stimulation. The modulation of transcription for known co-
stimulatory molecules CD80 and CD86 as well as the cytokine interleukin (IL)-12p40 in response to TLR stimulation in the same experiments are shown for
comparison. (C) The change in EphB2 protein expression at 22 hours post-incubation with LPS and IFN-γ is shown and the mean fluorescence quantified for
different conditions. All graphs represent the median value of pooled data across 3 independent BMDC preparations ±SD and data analyzed using One-way
ANOVA– Kruskal Wallis test and Dunn’s multiple comparisons post-test. *P<0.05. MFI = Mean Fluorescence Intensity.
doi:10.1371/journal.pone.0138835.g002
EphB2 Expression and Function on Dendritic Cells
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increase in EphrinB1, B2 and B3mRNA expression—in fact transcription of these molecules
appears to be downregulated at the same time point (S1 Fig). Altogether these data suggest that
treatment of BMDCs with TLR agonists LPS and CpG with or without IFN-γ upregulates tran-
scription of EphB2 but not ephrin B ligands.
To verify that these changes in transcription of EphB2 resulted in an increase in the levels of
EphB2 protein on the cell surface, immunofluorescence of BMDCs at 22 hours post-stimula-
tion was carried out and quantified according to the fluorescent intensity induced by binding
of anti-EphB2 antibody. There was a significant increase in EphB2 protein expression in
response to stimulation with both LPS and CpG that was further enhanced in the presence of
recombinant IFN-γ (Fig 2C), indicating that TLR stimulation upregulates the expression of
EphB2 protein on mouse BMDCs.
EphB2 deficiency on BMDCs does not affect pro-inflammatory cytokine
production when stimulated with TLR agonists in vitro
Mouse myeloid DC produce inflammatory cytokines when stimulated with TLR agonists [26,
27] and we have shown that EphB2 expression is upregulated by the TLR stimulation. To deter-
mine whether EphB2 is involved in the expression of cytokines by DCs activated by TLR liga-
tion, we compared the cytokine secretion profiles of EphB2-/- and EphB2+/+ BMDCs after
stimulation with LPS and CpG1668. We found that IL-12p40, IL-12p70, IL-10 and tumor
necrosis factor (TNF)-α were produced by LPS and CpG1668 stimulated BMDCs compared to
untreated cells (Fig 3). A trend towards increased IL-10 and TNF-α production was observed
in EphB2-/- BMDCs compared to EphB2+/+ BMDCs treated with CpG1668 and CpG1668
+ IFN-γ respectively (Fig 3). However there were no significant differences in the up-regulation
of any of the cytokines measured between EphB2+/+ and EphB2-/- BMDC. Altogether these
data show that the absence of EphB2 does not impair cytokine production in BMDCs in
response to TLR ligation.
EphB2 is upregulated on BMDCs in response to ligation with Ephrin B
ligands and co-localizes with MHC-II
During antigenic challenge, CD4+ T cells will only become fully activated upon contact with
DCs that present peptide loaded onto MHC-II molecules and display costimulatory molecules
that trigger a signalling network within the T cell to induce proliferation and cytokine produc-
tion. Contact between these molecules also provides feedback signals to the DCs to enhance
cytokine production and sustain expression of co-stimulatory molecules. Since previous studies
have suggested that EphB2 could be a co-stimulatory molecule for CD4+ T cell activation we
asked whether ligation of EphB2 receptor expressed on the DC cell surface was modulated by
ligation with Ephrin B ligands that are known to be expressed on the CD4+ T cell surface. Plate
bound EphrinB1 (Fig 4A) or EphrinB2 ligand (Fig 4D) upregulated transcription of EphB2 at 3
hours post-stimulation but for ephrin B1 stimulation this only occurred in the presence of
IFN-γ. The efficacy of the stimulation was assessed by global phosphorylation of tyrosine
kinases in the DCs, and EphrinB2 (Fig 4E and 4F), the main ligand for EphB2, was found to
induce more sustained phosphorylation than EphrinB1 (Fig 4B and 4C). This indicates that
ligation of EphB2 upregulates transcription of EphB2 in a positive feedback loop, and not all
Ephrin B ligand family members may equivalent effects on DCs activation.
When T cells interact with DCs, peptide-loaded MHC-II molecules co-localize with costimu-
latory molecules in lipid rafts [28]. For EphB2 to act as a co-stimulatory molecule for CD4+T
cells, it might be expected that this molecule would co-localize with MHC-II on DCs. The expres-
sion of MHC-II and EphB2 was analyzed on LPS-stimulated DCs by immunohistochemistry
EphB2 Expression and Function on Dendritic Cells
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and both molecules were found to co-localize (Fig 5) providing evidence that EphB2 potentially
works in concert with MHC-II in CD4+ T cell activation.
EphB2 deficiency does not affect T cell activation in vitro
Several co-stimulatory molecules have been described, and some studies have suggested that
the combination of molecules providing co-stimulation to stimulate CD4+ T cells may
Fig 3. Stimulation of BMDCs from EphB2+/+ and EphB2-/- mice with TLR receptor agonists results in similar levels of secreted cytokine. BMDCs
from EphB2+/+ and EphB2-/- mice were incubated with TLR ligands LPS and CpG1668 with and without the addition of recombinant interferon (IFN)-γ for 20
hours. Interleukin (IL)-12p40 (A), IL-12p70 (B), IL-10 (C) and tumor necrosis factor (TNF)-α (D) were measured in the culture supernatant using Luminex. The
graphs are representative of 3 individual experiments and bars represent the mean ±SD of 2 replicate wells plated.
doi:10.1371/journal.pone.0138835.g003
EphB2 Expression and Function on Dendritic Cells
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influence the phenotype of T helper cells that develop. We tested whether EphB2 influenced
the activation of CD4+T cells and the development of a Th1 phenotype as defined by their pro-
duction of IFN-γ. CD11c+ MHC-II+ BMDCs were matured from bone marrow of EphB2-/- or
EphB2+/+ littermate control mice (Fig 6A). To investigate whether EphB2 influenced the abil-
ity of BMDCs to process and present antigen to CD4+T cells BMDCs were cultured with OVA
protein or the OVA257-278 peptide and the MF2.2D9 T cell hybridoma engineered to express T
cell receptors specific for OVA257-278 [29]. Upon recognition of OVA257-278-loaded MHC-II on
BMDCs, the MF2.2D9 T cell hybridoma will secrete IL-2. As measured by a cell proliferation
bioassay, there was no significant difference in the secretion of IL-2 by MF2.2D9 cells incu-
bated with EphB2-/- BMDCs when compared with EphB2+/+ BMDCs in the presence of OVA
protein (Fig 6B) or OVA257-278 peptide (Fig 6C). This indicates that EphB2 deficiency does not
affect the processing and presentation of peptide to CD4+T cells. To assess whether EphB2
affected the skew of cytokines produced by CD4+T cells upon activation, EphB2-/- or EphB2
+/+ BMDCs were cultured for 5 days with OVA protein and OT-II T cells purified from the
Fig 4. BMDCs stimulated with EphrinB2 upregulate EphB2mRNA.Naïve BMDCs were plated onto plate-bound Ephrin-B1-Fc fusion protein (A, B, C) or
plate bound Ephrin-B2-Fc fusion protein (D, E, F). The transcription of EphB2with and without the addition of recombinant interferon-γ (IFN-γ) was monitored
by qPCR over 24 hours of culture (A, D). The efficiency of the Eph receptor ligation was monitored by assessing tyrosine phosphorylation on DCs by western
blot (B, E) and the phosphorylation quantified using densitometry (C, F). All graphs represent the median value of pooled data from 3 independent DC
preparations ±SD.
doi:10.1371/journal.pone.0138835.g004
EphB2 Expression and Function on Dendritic Cells
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spleens of naïve OT-II T cell receptor transgenic mice that have CD4+T cells expressing T cell
receptors specific for the OVA323-339 peptide of OVA [21]. By intracellular staining and flow
cytometry, we were able to detect OT-II CD4+T cells expressing IFN-γ (Fig 6D) but not IL-4
(Fig 6E) in this assay. However, there was no statistically significant difference between the per-
centages of IFN-γ+CD4+ Th1 cells activated by BMDCs with an EphB2 deficiency compared
with intact BMDCs (Fig 6E). Collectively these data indicate that EphB2 expression on DCs is
not required for the development of IFN-γ producing Th1 cells.
Redundancy in DC-expressed EphB receptor family members may
explain the negligible role of EphB2 in CD4+ T cell activation
The EphB receptor family is promiscuous with respect to binding to Ephrin B ligands [30]. In a
given cell type, the absence of one member of this family of receptor kinases could be comple-
mented/compensated by the others conferring functional redundancy [31]. By looking at the
breadth of expression of EphB receptors on naïve BMDCs we show that mouse BMDCs tran-
scribe RNA for EphB3, EphB4 and EphB6 in addition to EphB2 (Fig 7A) and confirmed that
this transcription pattern was mirrored by the expression of these molecules using immunohis-
tochemistry of BMDCs (Fig 7B). We found a similar pattern of transcription in mouse splenic
CD11c+ DC (Fig 7A). EphB1 was not transcribed or expressed on mouse splenic CD11c+ or
bone marrow-derived DCs (Fig 7B). To determine whether this pattern is mirrored in human
DCs, we tested transcription of EphB receptor family members in human monocyte-derived
DC, and found that EphB3 and EphB6 are transcribed in addition to EphB2 confirming that
both mouse and human DCs appear to express multiple members of the EphB receptor family
(Fig 7B).
Fig 5. EphB2 co-localizes with MHC-II on BMDCs. Two examples are shown: (A) Representative BMDCs stimulated with 1μg/ml lipopolysaccharide (LPS)
and 20ng/ml recombinant mouse interferon (IFN)-γ for 22 hours; (B) shows unstimulated cells. EphB2 is shown in red (Northernlights557), MHC-II is shown in
green (FITC) and DAPI is shown to demarcate the nuclei of the cells. Magnification 100x; Scale bar, 20μm.
doi:10.1371/journal.pone.0138835.g005
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Since DCs can express several members of the EphB receptor family, we determined
whether transcriptions of EphB receptors other than EphB2 were modulated by TLR stimula-
tion. We undertook qPCR of BMDCs stimulated with LPS or CPG1668 and observed that, in
addition to EphB2, EphB3 was upregulated by both stimuli (S2 Fig), demonstrating that EphB2
and EphB3 are co-modulated by TLR stimulation of BMDCs in mice. This lends weight to the
hypothesis that Eph receptor redundancy may explain the lack of an effect of EphB2 deficiency
on DC activation of CD4+T cells. EphB4 and EphB6 mRNA and proteins were not modulated
in these assays (data not shown).
Discussion
The role of the Eph receptor and ephrin ligand family of molecules in the induction of immune
responses has not been adequately determined. The rationale that these molecules may be
involved in immune responses is driven by the expression of these molecules in multiple
immune cell types including DCs [3, 17, 18], T cells [9, 32] and monocytes [20]. They are also
Fig 6. EphB2 is not required for development of Th1 cells in culture. BMDCs were matured frommouse bone marrow (A) and incubated with the
MF2.2D9 T cell hybridoma and chicken ovalbumin (OVA) (B) or OVA257-278 peptide (C) for 18 hours. The amount of IL-2 secreted by the MF2.2D9 T cell
hybridoma was measured using HT-2 cells and the cell number enumerated using an ATP-luminescence assay. The graphs represent the mean value ±SD
of 3 replicate wells for each dilution of EphB2-/- BMDCs (gray lines) or littermate control BMDCs (black lines). Circles represent no addition of a stimulus and
stimulated BMDCs are represented by squares. (D) BMDCs derived from bone marrow of EphB2-/- or EphB2+/+ mice were incubated with splenic CD4+ T
cells purified from naïve OT-II T cell receptor transgenic mice (n = 5) and OVA protein for 5 days. The development and expansion of Th1 and Th2 cells were
measured by intracellular staining of interferon (IFN)-γ and interleukin (IL)-4 respectively (E). All graphs are representative of at least 2 experiments, with the
exception of (E) which is the median value of pooled data ±SD from 3 separate preparations of BMDCs.
doi:10.1371/journal.pone.0138835.g006
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expressed on cells that are known to interact with the immune system including endothelial
cells [33] and platelets [34]. Despite this, very little is known about their exact function and
how they are regulated in response to the many signals that immune cells receive during an
immune response.
Mature T cells from mice express EphB receptors [11, 35, 36] as well as Ephrin B ligands
[10, 11]. Given that the function of Ephrin B ligands has been investigated on T cells in several
reports [12, 15, 32], we set out to examine the expression of EphB2 receptor on DCs, the main
antigen presenting cells that interact with T cells at the initiation of an immune response. Our
data show that mouse and human-derived myeloid DC express EphB receptors (Figs 1 and 7).
However, contrary to other reports demonstrating the expression of EphB1 receptor on
Fig 7. DCs express Eph receptors other than EphB2.RNA was extracted from naïve bone marrow-derived DCs (A), splenic DCs (B) and human
monocyte-derived DCs (C) and PCR performed using primers specific for mouse and human EphB receptors. The protein expression of the EphB receptor
family was detected using immunohistochemistry on naïve mouse BMDCs (D) and the expression compared to that detected using isotype controls.
Magnification 40x; Scale bar, 10μm.
doi:10.1371/journal.pone.0138835.g007
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Langerhans cells and interstitial DCs [3, 17], mouse BMDCs and CD11chi splenic DC tran-
scribed RNA for all EphB receptors apart from EphB1 (Fig 7A and 7B), a pattern mirrored by
the transcription profile in human Mo-DC (Fig 7A).
We reasoned that once DCs become activated in response to antigenic stimuli they will up-
regulate various molecules at their surface, including the EphB2 receptor, and this will facilitate
their binding to, and interaction with, EphrinB-expressing T cells. The immune response will
normally be initiated by activation of DCs upon ligation of pattern recognition receptors
(PRRs) such as TLRs by molecules containing pathogen-associated molecular patterns
(PAMPs) [37] at the site of an infection. We have shown that EphB2 is up-regulated by TLR
ligation on BMDCs (Fig 2) and also in a feedback loop upon ligation with EphrinB ligands (Fig
4). EphB receptors expressed on T cells have been shown to co-localize with the T cell receptor
[10, 11, 13] suggesting that this family of molecules are intimately interlinked with the
TCR-MHC interface in the interaction between T cells and antigen presenting cells. However
given that DC-expressed ephrin B ligands are not modulated by TLR stimulation (S1 Fig) we
focused on the role of T cell-expressed ephrin B ligands in T cell activation upon ligation with
DC-expressed EphB receptors.
Migration of activated DCs to the draining lymph nodes results in interaction with T cells
in the T cell zone. In addition to co-stimulation, and secretion of cytokines, the presentation of
pathogen-derived peptides in the context of MHC molecules on the surface of the DC to T cell
receptors drives the activation of T cells and initiates cell-mediated immune responses. Here
we observed co-localization between EphB2 and MHC-II on the surface of activated BMDCs
(Fig 5) suggesting a role for EphB2 in CD4+T cell activation. Given that macrophage expressed
EphB2 supports adhesion to EphrinB2-expressing endothelial cells [33], we hypothesized that
DCs that do not express EphB2 may have an impaired ability to adhere to ephrinB expressing
CD4+T cells in turn altering T cell activation. However we did not find that EphB2 expression
on DC was necessary for induction of CD4+T cell activation (Fig 6E).
The proliferation and differentiation of subsets of CD4+T cells secreting particular cyto-
kines is required to orchestrate effector functions appropriate to killing of different invading
pathogens [28, 37]. In this study we examined how EphB receptors expressed on DCs may
influence the development of IFN-γ-secreting Th1 cells and IL-4-secreting Th2 cells, focusing
on the role of EphB2 using BMDCs from EphB2 deficient [22] or intact mice as antigen pre-
senting cells. We did not see any significant level of IL-4 producing OT-II T cells in this assay
but equivalent numbers of IFN-γ producing OT-II cells expanded when stimulated with
EphB2-/- or EphB2+/+ DCs (Fig 6E). This is consistent with the equivalent levels of IL-12p70
expressed by BMDCs matured from EphB2-/- or EphB2+/+ animals upon TLR ligation (Fig 3).
We hypothesize that this result may have arisen due to redundancy between the members of
the EphB receptor family that are expressed on DCs (Fig 7) and also modulated in response to
TLR ligation (Fig 2 and S2 Fig).
Although we were unable to demonstrate any effect of ephrin B ligand stimulation by DC-
expressed EphB2 on Th1 development the expression of EphB receptors on T cells raises the
possibility that T cells use their EphrinB ligands to ligate with EphB receptors on other T cells.
Indeed this phenomenon has been described for other molecules known to function as co-stimu-
latory molecules, such as the B7 family members CD80 and CD86 and CD28 [38]. Ligation of
EphB receptors on the T cell surface induces signaling pathways in T cells that result in prolifera-
tion and activation of T cells, albeit to a lesser extent than with CD28 stimulation [10, 11].
EphB6 has been shown to generally be required for optimal production of IL-2, IFN-γ and IL-4
production from T cells in response to α-CD3 / α-CD28 stimulation even though it does not
contain an active intracellular kinase domain [35, 39]. Interestingly the ligation of EphB recep-
tors on the T cell surface at the time of stimulation leads to the development of Th1, but not Th2
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cells [10]. Although there may be differing role of EphB and ephrin ligation on the T cell surface
with respect to the development of Th1 cells, there has been no reported role for potential co-
stimulation of T cells by EphB / ephrinB molecules specifically leading to development of Th2
cells. Our data suggest that the B family of Eph / ephrins are not involved in Th2 development.
In summary, our data show for the first time that TLR ligation can modulate the expression
of EphB receptors on DCs. Although EphB2 co-localizes with MHC-II suggesting a role for T
cell activation, we also show that DC-expressed EphB2 is not a required molecule for CD4+T
cell activation and Th1 development. We hypothesize a redundancy in the roles that DC-
expressed EphB receptors play in CD4+T cell activation and our data suggest additional studies
should be carried out to elucidate the other functions that EphB receptors might play in DCs
biology.
Supporting Information
S1 Table. Primers used for qPCR.
(DOC)
S1 Fig. Transcription of EphrinB ligands is mostly downregulated by ligation with Toll-like
receptor ligands. (A) BMDCs were incubated with a Toll-like receptor (TLR)4 agonist (lipo-
polysaccharide (LPS) 1μg/ml) and (B) a TLR9 agonist (CpG1668 1μM) +/- recombinant
mouse interferon (IFN)-γ 20ng/ml and EphrinB1, EphrinB2 and EphrinB3mRNA quantified
by qPCR at different time points post-stimulation.
(TIF)
S2 Fig. Transcription of EphB3 is modulated by ligation with Toll-like receptor ligands.
(A) BMDCs were incubated with a Toll-like receptor (TLR)4 agonist (lipopolysaccharide (LPS)
1μg/ml) and (B) a TLR9 agonist (CpG1668 1μM) +/- recombinant mouse interferon (IFN)-γ
20ng/ml and EphB3mRNA quantified by qPCR at different time point post-stimulation. (C)
The change in EphB3 protein expression at 22 hours post-incubation with LPS, CpG1668 and
recombinant mouse IFN-γ is shown and the mean fluorescence quantified for different condi-
tions. All graphs represent the median value of pooled data across 3 independent dendritic cell
preparations ±SD and data analyzed using One-way ANOVA– Kruskal Wallis test and Dunn’s
multiple comparisons post-test. P<0.05. MFI = Mean Fluorescence Intensity.
(TIF)
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